ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Strs Ohio closes position in ANIP / ANI Pharmaceuticals, Inc.

On February 2, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 0 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 30, 2025 disclosing 3,600 shares of ANI Pharmaceuticals, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-02 2025-12-31 13F ANI PHARMACEUTICALS COM_STK 00182C103 0 -100.00 0
2025-10-30 2025-09-30 13F ANI PHARMACEUTICALS COM_STK 00182C103 3,600 3,600 330 0.0012
2024-08-05 2024-06-30 13F ANI PHARMACEUTICALS COM_STK 00182C103 0 -3,300 -100.00 0 0.0000
2024-05-13 2024-03-31 13F ANI PHARMACEUTICALS COM_STK 00182C103 3,300 -200 -5.71 0 0.0009
2024-01-30 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 3,500 0 0.00 0 0.0008
2023-10-26 2023-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 3,500 0 0.00 0 0.0009
2023-10-26 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 3,500 0 0 0.0009
2023-07-31 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 3,500 3,500 0 0.0008
2021-04-23 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -21,700 -100.00 0 -100.00
2021-01-25 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 21,700 2,300 11.86 630 15.17 0.0024
2020-12-14 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 19,400 7,400 61.67 547 40.98 0.0023
2020-07-23 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,000 1,000 9.09 388 -13.39 0.0017
2020-04-23 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,000 0 0.00 448 -33.92 0.0024
2020-01-24 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 11,000 1,300 13.40 678 -3.97 0.0028
2019-10-21 2019-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 9,700 600 6.59 706 -5.61 0.0031
2019-10-21 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,700 -1,300 706 3,124.7952
2019-07-25 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,100 -1,600 -14.95 748 -0.80 0.0033
2019-04-19 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,700 -1,300 -10.83 754 39.63 0.0034
2019-01-23 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 12,000 -1,500 -11.11 540 -29.23 0.0027
2018-10-19 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 13,500 1,300 10.66 763 -6.27 0.0033
2018-08-06 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,200 1,800 17.31 814 34.55 0.0035
2018-04-20 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,400 10,400 605 0.0027
2017-07-26 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -13,700 -100.00 0 -100.00
2017-04-26 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 13,700 3,100 29.25 678 5.61 0.0029
2017-01-24 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 10,600 0 0.00 642 -8.68 0.0028
2016-10-27 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 10,600 -1,500 -12.40 703 4.15 0.0031
2016-07-26 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,100 900 8.04 675 79.52 0.0030
2016-04-25 2016-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 11,200 0 0.00 376 -25.54 0.0017
2016-01-28 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 11,200 -1,000 -8.20 505 4.77 0.0023
2015-10-21 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12,200 0 0.00 482 -36.33 0.0023
2015-08-04 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,200 0 0.00 757 -0.79 0.0033
2015-04-27 2015-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 12,200 -700 -5.43 763 4.95 0.0034
2015-04-21 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 12,200 763
2015-01-23 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 12,900 -3,300 -20.37 727 58.73 0.0032
2014-10-29 2014-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 16,200 13,900 604.35 458 479.75 0.0020
2014-10-20 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 16,200 458
2014-07-24 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,300 2,300 79 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.